Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-038862
Filing Date
2025-03-13
Accepted
2025-03-13 17:01:04
Documents
6
Effectiveness Date
2025-03-13

Document Format Files

Seq Description Document Type Size
1 S-8 rgnx-s8-2025-03-13.htm S-8 86613
2 EX-5.1 rgnx-ex5_1.htm EX-5.1 9702
3 EX-23.1 rgnx-ex23_1.htm EX-23.1 4398
4 EX-FILING FEES rgnx-exfiling_fees.htm EX-FILING FEES 32510
5 GRAPHIC img252287865_0.jpg GRAPHIC 11967
6 GRAPHIC img252287865_1.jpg GRAPHIC 8618
  Complete submission text file 0000950170-25-038862.txt   163072
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285797 | Film No.: 25736682
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)